S155: EFFICACY AND SAFETY RESULTS FROM ASCEMBL, A PHASE 3 STUDY OF ASCIMINIB VS BOSUTINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE AFTER ≥2 PRIOR TYROSINE KINASE INHIBITORS: WK 96 UPDATE

• D. Rea,
• A. Hochhaus,
• M. J. Mauro,
• Y. Minami,
• E. Lomaia,
• S. Voloshin,
• A. Turkina,
• D.-W. Kim,
• J. F. Apperley,
• J. E. Cortes,
• A. Abdo,
• L. M. Fogliatto,
• D. D. H Kim,
• P. le Coutre,
• S. Saussele,
• M. Annunziata,
• T. P. Hughes,
• N. Chaudhri,
• L. Chee,
• V. García-Gutiérrez,
• K. Sasaki,
• S. Kapoor,
• A. Allepuz,
• S. Quenet,
• V. Bédoucha,
• C. Boquimpani

Affiliations

D. Rea

1 Hôpital Saint-Louis, Paris, France

A. Hochhaus

2 Universitätsklinikum Jena, Jena, Germany

M. J. Mauro

3 Memorial Sloan Kettering Cancer Center, New York, United States of America

Y. Minami

4 National Cancer Center Hospital East, Kashiwa, Japan

E. Lomaia

5 Almazov National Medical Research Centre

S. Voloshin

6 Russian Research Institute of Hematology and Transfusiology, St. Petersburg

A. Turkina

7 National Medical Research Center for Hematology, Moscow, Russia

D.-W. Kim

8 Uijeongbu Eulji Medical Center, Geumo-dong, Uijeongbu-si, South Korea

J. F. Apperley

9 Centre for Haematology Imperial College London, London, United Kingdom

J. E. Cortes

10 Georgia Cancer Center, Augusta, United States of America

A. Abdo

11 Instituto do Câncer do Estado de São Paulo (ICESPSP), São Paulo

L. M. Fogliatto

12 Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, Brazil

D. D. H Kim

13 Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada

P. le Coutre

14 Charité–Universitätsmedizin Berlin, Berlin

S. Saussele

15 III. Medizinische Klinik, Medizinische Fakultät Mannheim der Universität Heidelberg, Mannheim, Germany

M. Annunziata

16 Division of Hematology, AORN Cardarelli, Naples, Italy

T. P. Hughes

17 South Australian Health and Medical Research Institute and University of Adelaide, Adelaide, Australia

N. Chaudhri

18 King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia

L. Chee

19 Peter MacCallum Cancer Center and The Royal Melbourne Hospital, Victoria, Australia

V. García-Gutiérrez

20 Servicio de Hematología, Hospital Universitario Ramón y Cajal (IRYCIS), Madrid, Spain

K. Sasaki

21 The University of Texas MD Anderson Cancer Center, Houston

S. Kapoor

22 Novartis Pharmaceuticals Corporation, East Hanover, United States of America

A. Allepuz

23 Novartis Pharma AG, Basel, Switzerland

S. Quenet

23 Novartis Pharma AG, Basel, Switzerland

V. Bédoucha

23 Novartis Pharma AG, Basel, Switzerland

C. Boquimpani

24 HEMORIO, State Institute of Hematology Arthur de Siquiera Cavalcanti, Rio de Janeiro, Brazil Oncoclínica Centro de Tratamento Oncológico, Rio de Janeiro, Brazil